article thumbnail

Largest Human Trial To Date Will Review Safety Of Full Spectrum Hemp Products

SpeedWeed

As is the case in the United States, Europe lacks sufficiently reliable scientific data to support the safety of products infused with full spectrum hemp extract. In January 2019, the European Union (EU) reclassified extracts of cannabis sativa L. Read the entire article at The Fresh Toast. View original article.

Safety 52
article thumbnail

Press Release: This is the FIRST Public Psychedelics Company to Notch a Patent for Extracting Natural Psilocybin

Cannabis Law Report

To support its mission, the company has a robust portfolio of extraction and purification methods, a botanical extraction management team, a Health Canada psilocybin Dealer’s License, and in-house GMP manufacturing capabilities. We are proud to lead the industry with this first issued natural extraction patent.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CRN Denounces FDA Rejection of New Dietary Ingredient Notifications for Hemp Extract Containing CBD, Urges Congress to Act

Cannabis Law Report

The following is a statement from CRN President & CEO Steve Mister: “CRN is extremely disappointed to learn that FDA rejected NDI notifications for full-spectrum hemp extract containing CBD submitted earlier this year by supplement manufacturers Charlotte’s Web and Irwin Naturals. In December 2019, CRN and FDA met to discuss these issues.

article thumbnail

Article: Workplace exposures in the cannabis industry

Cannabis Law Report

Laura Davis; environmental, health and safety consultant; YellowBird ; Phoenix writes. It’s been a decade since Colorado legalized cannabis for recreational use, but the industry still has a long way to go to effectively and consistently ensure the safety of marijuana cultivators, extractors, lab workers and retail representatives.

Safety 105
article thumbnail

Report: Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis

Cannabis Law Report

Scientific Reports volume 11 , Article number: 23462 ( 2021 ) Cite this article. Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Metrics details.

Safety 52
article thumbnail

FDA Rejects Filing of Charlotte’s Web Hemp as a Dietary Extract |

SpeedWeed

In addition, your NDI 1202 contains a significant amount of CBD per mL and you also appear to market ‘full-spectrum hemp extract’-containing products as CBD products.”. The FDA letter asserts that a FSHE cannot be used in dietary supplements because it is precluded and expresses safety concerns. View original article.

article thumbnail

Virginia Announces New Policy Allowing the Production of Hemp Extracts

Cannabis Law Report

Under a new policy announced by the Northam Administration, the Commonwealth of Virginia will soon officially authorize hemp processors to produce hemp extracts for human consumption. VDACS will soon issue, through its food safety program, rules for hemp processors to follow when producing hemp extracts.